Emsam Drug Interactions

Emsam Interactions Explained

The following sections explain in detail the potentially negative interactions that can occur when Emsam is combined with any of the drugs listed above.
 
Apraclonidine (Iopidine)
You should not use apraclonidine eye drops while taking Emsam, due to the risk of dangerously high blood pressure (hypertension).
 
Atomoxetine (Strattera)
Strattera and Emsam should not be taken together, or within two weeks of each other, due to the risk of dangerous side effects.
 
Brimonidine (Alphagan P)
You should not use brimonidine eye drops while taking Emsam due to the risk of dangerously high blood pressure.
 
Buspirone (BuSpar)
You should not take buspirone while taking Emsam (or if you have taken Emsam within the past 14 days) due to the risk of dangerously high blood pressure.
 
Caffeine
You should use caffeine sparingly while taking Emsam due to the risk of dangerously high blood pressure. Be aware that many foods and medicines (such as "stay-awake" products and migraine products) contain caffeine.
 
Carbamazepine (Tegretol, Tegretol XR)
Due to the risk of dangerous side effects (such as high blood pressure or seizures), you should not take carbamazepine and Emsam within two weeks of each other.
 
Cough, Cold, and Allergy Products
Taking Emsam with many cough, cold, and allergy products (including eye drops or nasal products) can increase your risk of dangerous side effects, such as high blood pressure. Most of these products should never be taken with Emsam. While you are taking Emsam, always check with your healthcare provider before taking any cough, cold, or allergy products.
Healthy Pet, Healthy You

Emsam Patch

Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2016 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.